{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:07:18Z","timestamp":1771466838878,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T00:00:00Z","timestamp":1644192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770336"],"award-info":[{"award-number":["81770336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province","award":["xtcx-2016-16 to XD"],"award-info":[{"award-number":["xtcx-2016-16 to XD"]}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"crossref","award":["Seeding Grant"],"award-info":[{"award-number":["Seeding Grant"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s12012-022-09722-0","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T05:02:36Z","timestamp":1644210156000},"page":"404-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiac Expression of Esophageal Cancer-Related Gene-4 is Regulated by Sp1 and is a Potential Early Target of Doxorubicin-Induced Cardiotoxicity"],"prefix":"10.1007","volume":"22","author":[{"given":"Dandan","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3076-6237","authenticated-orcid":false,"given":"Xitong","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,7]]},"reference":[{"issue":"4","key":"9722_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/1097-0142(1971)28:4<844::aid-cncr2820280407>3.0.co;2-9","volume":"28","author":"E Middleman","year":"1971","unstructured":"Middleman, E., Luce, J., & Frei, E., 3rd. (1971). Clinical trials with adriamycin. Cancer, 28(4), 844\u2013850. https:\/\/doi.org\/10.1002\/1097-0142(1971)28:4%3c844::aid-cncr2820280407%3e3.0.co;2-9","journal-title":"Cancer"},{"issue":"18","key":"9722_CR2","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","volume":"67","author":"YL Lyu","year":"2007","unstructured":"Lyu, Y. L., Kerrigan, J. E., Lin, C. P., Azarova, A. M., Tsai, Y. C., Ban, Y., & Liu, L. F. (2007). Topoisomerase IIbeta mediated DNA double-strand breaks: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Research, 67(18), 8839\u20138846. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1649","journal-title":"Cancer Research"},{"issue":"1","key":"9722_CR3","doi-asserted-by":"publisher","first-page":"13672","DOI":"10.1038\/s41598-018-31939-9","volume":"8","author":"H Taymaz-Nikerel","year":"2018","unstructured":"Taymaz-Nikerel, H., Karabekmez, M. E., Eraslan, S., & Kirdar, B. (2018). Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cells. Scientific Reports, 8(1), 13672. https:\/\/doi.org\/10.1038\/s41598-018-31939-9","journal-title":"Scientific Reports"},{"issue":"5","key":"9722_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.pcad.2006.10.002","volume":"49","author":"G Takemura","year":"2007","unstructured":"Takemura, G., & Fujiwara, H. (2007). Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Progress in Cardiovasc Diseases, 49(5), 330\u2013352. https:\/\/doi.org\/10.1016\/j.pcad.2006.10.002","journal-title":"Progress in Cardiovasc Diseases"},{"issue":"2","key":"9722_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11864-020-00812-1","volume":"22","author":"M Russo","year":"2021","unstructured":"Russo, M., Della Sala, A., Tocchetti, C. G., Porporato, P. E., & Ghigo, A. (2021). Metabolic aspects of anthracycline cardiotoxicity. Current Treatment Options in Oncology, 22(2), 18. https:\/\/doi.org\/10.1007\/s11864-020-00812-1","journal-title":"Current Treatment Options in Oncology"},{"issue":"2","key":"9722_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000265166","volume":"115","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S. (2010). Doxorubicin cardiomyopathy. Cardiology, 115(2), 155\u2013162. https:\/\/doi.org\/10.1159\/000265166","journal-title":"Cardiology"},{"key":"9722_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113480","author":"J Marinello","year":"2018","unstructured":"Marinello, J., Delcuratolo, M., & Capranico, G. (2018). Anthracyclines as topoisomerase II poisons: From early studies to new perspectives. International Journal of Moeculel Sciences. https:\/\/doi.org\/10.3390\/ijms19113480","journal-title":"International Journal of Moeculel Sciences"},{"key":"9722_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108834","volume":"313","author":"A Hanf","year":"2019","unstructured":"Hanf, A., Oelze, M., Manea, A., Li, H., Munzel, T., & Daiber, A. (2019). The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes. Chemo-Biology Interactions, 313, 108834. https:\/\/doi.org\/10.1016\/j.cbi.2019.108834","journal-title":"Chemo-Biology Interactions"},{"issue":"5","key":"9722_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","volume":"17","author":"Y Pommier","year":"2010","unstructured":"Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010). DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chemistry Biology, 17(5), 421\u2013433. https:\/\/doi.org\/10.1016\/j.chembiol.2010.04.012","journal-title":"Chemistry Biology"},{"key":"9722_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tox.2017.08.011","volume":"390","author":"A Ferreira","year":"2017","unstructured":"Ferreira, A., Cunha-Oliveira, T., Simoes, R. F., Carvalho, F. S., Burgeiro, A., Nordgren, K., Wallace, K. B., & Oliveira, P. J. (2017). Altered mitochondrial epigenetics associated with subchronic doxorubicin cardiotoxicity. Toxicology, 390, 63\u201373. https:\/\/doi.org\/10.1016\/j.tox.2017.08.011","journal-title":"Toxicology"},{"issue":"4","key":"9722_CR11","first-page":"254","volume":"20","author":"T Su","year":"1998","unstructured":"Su, T., Liu, H., & Lu, S. (1998). Cloning and identification of cDNA fragments related to human esophageal cancer. Zhonghua Zhong Liu Za Zhi, 20(4), 254\u2013257.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"5","key":"9722_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1189\/jlb.1011503","volume":"91","author":"A Baird","year":"2012","unstructured":"Baird, A., Coimbra, R., Dang, X., Lopez, N., Lee, J., Krzyzaniak, M., Winfield, R., Potenza, B., & Eliceiri, B. P. (2012). Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages. Journal of Leukocyte Biology, 91(5), 773\u2013781. https:\/\/doi.org\/10.1189\/jlb.1011503","journal-title":"Journal of Leukocyte Biology"},{"issue":"3","key":"9722_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1101\/gr.5755407","volume":"17","author":"O Mirabeau","year":"2007","unstructured":"Mirabeau, O., Perlas, E., Severini, C., Audero, E., Gascuel, O., Possenti, R., Birney, E., Rosenthal, N., & Gross, C. (2007). Identification of novel peptide hormones in the human proteome by hidden Markov model screening. Genome Research, 17(3), 320\u2013327. https:\/\/doi.org\/10.1101\/gr.5755407","journal-title":"Genome Research"},{"issue":"2","key":"9722_CR14","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.4081\/ejh.2015.2458","volume":"59","author":"A Porzionato","year":"2015","unstructured":"Porzionato, A., Rucinski, M., Macchi, V., Sarasin, G., Malendowicz, L. K., & De Caro, R. (2015). ECRG4 expression in normal rat tissues: Expression study and literature review. European Journal of Histochemistry, 59(2), 2458. https:\/\/doi.org\/10.4081\/ejh.2015.2458","journal-title":"European Journal of Histochemistry"},{"issue":"4","key":"9722_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061394","volume":"8","author":"A Kurabi","year":"2013","unstructured":"Kurabi, A., Pak, K., Dang, X., Coimbra, R., Eliceiri, B. P., Ryan, A. F., & Baird, A. (2013). Ecrg4 attenuates the inflammatory proliferative response of mucosal epithelial cells to infection. PLoS ONE, 8(4), e61394. https:\/\/doi.org\/10.1371\/journal.pone.0061394","journal-title":"PLoS ONE"},{"issue":"4","key":"9722_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/GICTT.S49085","volume":"2014","author":"A Baird","year":"2014","unstructured":"Baird, A., Lee, J., Podvin, S., Kurabi, A., Dang, X., Coimbra, R., Costantini, T., Bansal, V., & Eliceiri, B. P. (2014). Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy. Gastrointestinal Cancer, 2014(4), 131\u2013142. https:\/\/doi.org\/10.2147\/GICTT.S49085","journal-title":"Gastrointestinal Cancer"},{"issue":"1","key":"9722_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2045-8118-8-6","volume":"8","author":"AM Gonzalez","year":"2011","unstructured":"Gonzalez, A. M., Podvin, S., Lin, S. Y., Miller, M. C., Botfield, H., Leadbeater, W. E., Roberton, A., Dang, X., Knowling, S. E., Cardenas-Galindo, E., Donahue, J. E., Stopa, E. G., Johanson, C. E., Coimbra, R., Eliceiri, B. P., & Baird, A. (2011). Ecrg4 expression and its product augurin in the choroid plexus: Impact on fetal brain development, cerebrospinal fluid homeostasis and neuroprogenitor cell response to CNS injury. Fluids and Barriers of the CNS, 8(1), 6. https:\/\/doi.org\/10.1186\/2045-8118-8-6","journal-title":"Fluids and Barriers of the CNS"},{"issue":"9","key":"9722_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024609","volume":"6","author":"S Podvin","year":"2011","unstructured":"Podvin, S., Gonzalez, A. M., Miller, M. C., Dang, X., Botfield, H., Donahue, J. E., Kurabi, A., Boissaud-Cooke, M., Rossi, R., Leadbeater, W. E., Johanson, C. E., Coimbra, R., Stopa, E. G., Eliceiri, B. P., & Baird, A. (2011). Esophageal cancer related gene-4 is a choroid plexus-derived injury response gene: Evidence for a biphasic response in early and late brain injury. PLoS ONE, 6(9), e24609. https:\/\/doi.org\/10.1371\/journal.pone.0024609","journal-title":"PLoS ONE"},{"issue":"1","key":"9722_CR19","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1038\/s41598-017-02902-x","volume":"7","author":"L Huang","year":"2017","unstructured":"Huang, L., Yu, H., Fan, X., Li, X., Mao, L., Cheng, J., Zeng, X., & Dang, X. (2017). A potential role of esophageal cancer related gene-4 for atrial fibrillation. Scientific Reports, 7(1), 2717. https:\/\/doi.org\/10.1038\/s41598-017-02902-x","journal-title":"Scientific Reports"},{"key":"9722_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-019-0701-0","author":"R Zhou","year":"2019","unstructured":"Zhou, R., Liu, Y., Huang, W., & Dang, X. (2019). Potential functions of esophageal cancer-related gene-4 in the cardiovascular system. Frontiers in Medicine. https:\/\/doi.org\/10.1007\/s11684-019-0701-0","journal-title":"Frontiers in Medicine"},{"issue":"6","key":"9722_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1089\/sur.2014.209","volume":"16","author":"TW Costantini","year":"2015","unstructured":"Costantini, T. W., Coimbra, R., Lopez, N. E., Lee, J. G., Potenza, B., Smith, A., Baird, A., & Eliceiri, B. P. (2015). Monitoring neutrophil-expressed cell surface esophageal cancer related gene-4 after severe burn injury. Surgical Infections (Larchmt), 16(6), 669\u2013674. https:\/\/doi.org\/10.1089\/sur.2014.209","journal-title":"Surgical Infections (Larchmt)"},{"issue":"5","key":"9722_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/carcin\/bgs118","volume":"33","author":"J Matsuzaki","year":"2012","unstructured":"Matsuzaki, J., Torigoe, T., Hirohashi, Y., Kamiguchi, K., Tamura, Y., Tsukahara, T., Kubo, T., Takahashi, A., Nakazawa, E., Saka, E., Yasuda, K., Takahashi, S., & Sato, N. (2012). ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells. Carcinogenesis, 33(5), 996\u20131003. https:\/\/doi.org\/10.1093\/carcin\/bgs118","journal-title":"Carcinogenesis"},{"key":"9722_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gene.2017.08.041","volume":"636","author":"X Dang","year":"2017","unstructured":"Dang, X., Zeng, X., Coimbra, R., Eliceiri, B. P., & Baird, A. (2017). Counter regulation of ECRG4 gene expression by hypermethylation-dependent inhibition and the Sp1 transcription factor-dependent stimulation of the c2orf40 promoter. Gene, 636, 103\u2013111. https:\/\/doi.org\/10.1016\/j.gene.2017.08.041","journal-title":"Gene"},{"issue":"9","key":"9722_CR24","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1111\/jcmm.14474","volume":"23","author":"R Zhou","year":"2019","unstructured":"Zhou, R., Huang, W., Fan, X., Liu, F., Luo, L., Yuan, H., Jiang, Y., Xiao, H., Zhou, Z., Deng, C., & Dang, X. (2019). miR-499 released during myocardial infarction causes endothelial injury by targeting alpha7-nAchR. Journal of Cellular and Molecular Medicine, 23(9), 6085\u20136097. https:\/\/doi.org\/10.1111\/jcmm.14474","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"2 Pt 2","key":"9722_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.gene.2015.08.067","volume":"575","author":"D Xitong","year":"2016","unstructured":"Xitong, D., & Xiaorong, Z. (2016). Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases. Gene, 575(2 Pt 2), 377\u2013384. https:\/\/doi.org\/10.1016\/j.gene.2015.08.067","journal-title":"Gene"},{"key":"9722_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/1061186X.2021.1929257","author":"Y Yu","year":"2021","unstructured":"Yu, Y., Li, W., Mao, L., Peng, W., Long, D., Li, D., Zhou, R., & Dang, X. (2021). Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: A potential formulation for the treatment of Alzheimer\u2019s disease. Journal of Drug Targeting. https:\/\/doi.org\/10.1080\/1061186X.2021.1929257","journal-title":"Journal of Drug Targeting"},{"issue":"2","key":"9722_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/dna.2016.3507","volume":"36","author":"J Wang","year":"2017","unstructured":"Wang, J., Jin, Y., & Cattini, P. A. (2017). Expression of the cardiac maintenance and survival factor FGF-16 gene is regulated by Csx\/Nkx25 and is an early target of doxorubicin cardiotoxicity. DNA and Cell Biology, 36(2), 117\u2013126. https:\/\/doi.org\/10.1089\/dna.2016.3507","journal-title":"DNA and Cell Biology"},{"issue":"16","key":"9722_CR28","first-page":"4488","volume":"54","author":"Q Zhu","year":"1994","unstructured":"Zhu, Q., & Center, M. S. (1994). Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Research, 54(16), 4488\u20134492.","journal-title":"Cancer Research"},{"issue":"3","key":"9722_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00441-012-1396-6","volume":"348","author":"X Dang","year":"2012","unstructured":"Dang, X., Podvin, S., Coimbra, R., Eliceiri, B., & Baird, A. (2012). Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4. Cell and Tissue Research, 348(3), 505\u2013514. https:\/\/doi.org\/10.1007\/s00441-012-1396-6","journal-title":"Cell and Tissue Research"},{"issue":"5","key":"9722_CR30","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/me.2010-0389","volume":"25","author":"A Ozawa","year":"2011","unstructured":"Ozawa, A., Lick, A. N., & Lindberg, I. (2011). Processing of proaugurin is required to suppress proliferation of tumor cell lines. Molecular Endocrinology, 25(5), 776\u2013784. https:\/\/doi.org\/10.1210\/me.2010-0389","journal-title":"Molecular Endocrinology"},{"issue":"12","key":"9722_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1242547","volume":"5","author":"T Moriguchi","year":"2016","unstructured":"Moriguchi, T., Kaneumi, S., Takeda, S., Enomoto, K., Mishra, S. K., Miki, T., Koshimizu, U., Kitamura, H., & Kondo, T. (2016). Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling. Oncoimmunology, 5(12), e1242547. https:\/\/doi.org\/10.1080\/2162402X.2016.1242547","journal-title":"Oncoimmunology"},{"issue":"1","key":"9722_CR32","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1038\/s41598-018-22440-4","volume":"8","author":"T Moriguchi","year":"2018","unstructured":"Moriguchi, T., Takeda, S., Iwashita, S., Enomoto, K., Sawamura, T., Koshimizu, U., & Kondo, T. (2018). Ecrg4 peptide is the ligand of multiple scavenger receptors. Scientific Reports, 8(1), 4048. https:\/\/doi.org\/10.1038\/s41598-018-22440-4","journal-title":"Scientific Reports"},{"key":"9722_CR33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3389\/fgene.2020.00846","volume":"11","author":"X Liang","year":"2020","unstructured":"Liang, X., Gao, J., Wang, Q., Hou, S., & Wu, C. (2020). ECRG4 represses cell proliferation and invasiveness via NFIC\/OGN\/NF-kappaB signaling pathway in bladder cancer. Frontiers in Genetics, 11, 846. https:\/\/doi.org\/10.3389\/fgene.2020.00846","journal-title":"Frontiers in Genetics"},{"key":"9722_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/1471-2407-9-447","volume":"9","author":"S Gotze","year":"2009","unstructured":"Gotze, S., Feldhaus, V., Traska, T., Wolter, M., Reifenberger, G., Tannapfel, A., Kuhnen, C., Martin, D., Muller, O., & Sievers, S. (2009). ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer, 9, 447. https:\/\/doi.org\/10.1186\/1471-2407-9-447","journal-title":"BMC Cancer"},{"issue":"7","key":"9722_CR35","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1172\/JCI43068","volume":"121","author":"JC Perman","year":"2011","unstructured":"Perman, J. C., Bostrom, P., Lindbom, M., Lidberg, U., StAhlman, M., Hagg, D., Lindskog, H., Scharin Tang, M., Omerovic, E., Mattsson Hulten, L., Jeppsson, A., Petursson, P., Herlitz, J., Olivecrona, G., Strickland, D. K., Ekroos, K., Olofsson, S. O., & Boren, J. (2011). The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction. Journal of Clinical Investigation, 121(7), 2625\u20132640. https:\/\/doi.org\/10.1172\/JCI43068","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"9722_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13046-019-1203-2","volume":"38","author":"B Zhang","year":"2019","unstructured":"Zhang, B., Song, L., Cai, J., Li, L., Xu, H., Li, M., Wang, J., Shi, M., Chen, H., Jia, H., & Hou, Z. (2019). The LIM protein Ajuba\/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation. Journal of Experimental and Clinical Cancer Research, 38(1), 205. https:\/\/doi.org\/10.1186\/s13046-019-1203-2","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"issue":"11","key":"9722_CR37","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1101\/gad.5.11.1935","volume":"5","author":"BF Pugh","year":"1991","unstructured":"Pugh, B. F., & Tjian, R. (1991). Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes and Development, 5(11), 1935\u20131945. https:\/\/doi.org\/10.1101\/gad.5.11.1935","journal-title":"Genes and Development"},{"issue":"5","key":"9722_CR38","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1006\/jmbi.1999.3213","volume":"293","author":"H Rotheneder","year":"1999","unstructured":"Rotheneder, H., Geymayer, S., & Haidweger, E. (1999). Transcription factors of the Sp1 family: Interaction with E2F and regulation of the murine thymidine kinase promoter. Journal of Molecular Biology, 293(5), 1005\u20131015. https:\/\/doi.org\/10.1006\/jmbi.1999.3213","journal-title":"Journal of Molecular Biology"},{"issue":"12","key":"9722_CR39","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1021\/acs.jnatprod.0c00350","volume":"83","author":"A Murugesan","year":"2020","unstructured":"Murugesan, A., Lassalle-Claux, G., Hogan, L., Vaillancourt, E., Selka, A., Luiker, K., Kim, M. J., Touaibia, M., & Reiman, T. (2020). Antimyeloma potential of caffeic acid phenethyl ester and its analogues through Sp1 mediated downregulation of IKZF1-IRF4-MYC Axis. Journal of Natural Products, 83(12), 3526\u20133535. https:\/\/doi.org\/10.1021\/acs.jnatprod.0c00350","journal-title":"Journal of Natural Products"},{"issue":"4","key":"9722_CR40","first-page":"513","volume":"89","author":"L O'Connor","year":"2016","unstructured":"O\u2019Connor, L., Gilmour, J., & Bonifer, C. (2016). The role of the ubiquitously expressed transcription factor Sp1 in tissue-specific transcriptional regulation and in disease. Yale Journal of Biology Medicine, 89(4), 513\u2013525.","journal-title":"Yale Journal of Biology Medicine"},{"key":"9722_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-015-0351-z","volume":"14","author":"S Koizume","year":"2015","unstructured":"Koizume, S., Ito, S., Nakamura, Y., Yoshihara, M., Furuya, M., Yamada, R., Miyagi, E., Hirahara, F., Takano, Y., & Miyagi, Y. (2015). Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer. Molecular Cancer, 14, 77. https:\/\/doi.org\/10.1186\/s12943-015-0351-z","journal-title":"Molecular Cancer"},{"issue":"33","key":"9722_CR42","doi-asserted-by":"publisher","first-page":"23943","DOI":"10.1074\/jbc.M113.489500","volume":"288","author":"L Xie","year":"2013","unstructured":"Xie, L., & Collins, J. F. (2013). Transcription factors Sp1 and Hif2alpha mediate induction of the copper-transporting ATPase (Atp7a) gene in intestinal epithelial cells during hypoxia. Journal of Biological Chemistry, 288(33), 23943\u201323952. https:\/\/doi.org\/10.1074\/jbc.M113.489500","journal-title":"Journal of Biological Chemistry"},{"key":"9722_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2019.114606","volume":"378","author":"J He","year":"2019","unstructured":"He, J., Liu, W., Ge, X., Wang, G. C., Desai, V., Wang, S., Mu, W., Bhardwaj, V., Seifert, E., Liu, L. Z., Bhushan, A., Peiper, S. C., & Jiang, B. H. (2019). Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation. Toxicology and Applied Pharmacology, 378, 114606. https:\/\/doi.org\/10.1016\/j.taap.2019.114606","journal-title":"Toxicology and Applied Pharmacology"},{"key":"9722_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2199-8-36","volume":"8","author":"AO Williams","year":"2007","unstructured":"Williams, A. O., Isaacs, R. J., & Stowell, K. M. (2007). Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions. BMC Molecular Biology, 8, 36. https:\/\/doi.org\/10.1186\/1471-2199-8-36","journal-title":"BMC Molecular Biology"},{"issue":"17","key":"9722_CR45","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1074\/jbc.271.45.28220","volume":"55","author":"T Kubo","year":"1995","unstructured":"Kubo, T., Kohno, K., Ohga, T., Taniguchi, K., Kawanami, K., Wada, M., & Kuwano, M. (1995). DNA topoisomerase II alpha gene expression under transcriptional control in etoposide\/teniposide-resistant human cancer cells. Cancer Research, 55(17), 3860\u20133864. https:\/\/doi.org\/10.1074\/jbc.271.45.28220","journal-title":"Cancer Research"},{"issue":"12","key":"9722_CR46","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1161\/CIRCULATIONAHA.107.734160","volume":"117","author":"B Levkau","year":"2008","unstructured":"Levkau, B., Schafers, M., Wohlschlaeger, J., von Wnuck Lipinski, K., Keul, P., Hermann, S., Kawaguchi, N., Kirchhof, P., Fabritz, L., Stypmann, J., Stegger, L., Flogel, U., Schrader, J., Fischer, J. W., Hsieh, P., Ou, Y. L., Mehrhof, F., Tiemann, K., Ghanem, A., \u2026 Baba, H. A. (2008). Survivin determines cardiac function by controlling total cardiomyocyte number. Circulation, 117(12), 1583\u20131593. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.734160","journal-title":"Circulation"},{"issue":"8","key":"9722_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135438","volume":"10","author":"BS Lee","year":"2015","unstructured":"Lee, B. S., Oh, J., Kang, S. K., Park, S., Lee, S. H., Choi, D., Chung, J. H., Chung, Y. W., & Kang, S. M. (2015). Insulin protects cardiac myocytes from doxorubicin toxicity by Sp1-mediated transactivation of survivin. PLoS ONE, 10(8), e0135438. https:\/\/doi.org\/10.1371\/journal.pone.0135438","journal-title":"PLoS ONE"},{"key":"9722_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.yjmcc.2019.12.007","volume":"138","author":"J Oh","year":"2020","unstructured":"Oh, J., Lee, B. S., Lim, G., Lim, H., Lee, C. J., Park, S., Lee, S. H., Chung, J. H., & Kang, S. M. (2020). Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition. Jouenal of Molecular and Cellular Cardiology, 138, 244\u2013255. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.12.007","journal-title":"Jouenal of Molecular and Cellular Cardiology"},{"issue":"17","key":"9722_CR49","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1158\/0008-5472.CAN-03-1476","volume":"64","author":"Y Uchida","year":"2004","unstructured":"Uchida, Y., Itoh, M., Taguchi, Y., Yamaoka, S., Umehara, H., Ichikawa, S., Hirabayashi, Y., Holleran, W. M., & Okazaki, T. (2004). Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60\/ADR cells. Cancer Research, 64(17), 6271\u20136279. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-1476","journal-title":"Cancer Research"},{"issue":"11","key":"9722_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048492","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang, X., Wu, X., Su, P., Gao, Y., Meng, B., Sun, Y., Li, L., Zhou, Z., & Zhou, G. (2012). Doxorubicin influences the expression of glucosylceramide synthase in invasive ductal breast cancer. PLoS ONE, 7(11), e48492. https:\/\/doi.org\/10.1371\/journal.pone.0048492","journal-title":"PLoS ONE"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-022-09722-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T07:18:22Z","timestamp":1649402302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-022-09722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,7]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["9722"],"URL":"https:\/\/doi.org\/10.1007\/s12012-022-09722-0","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,7]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Southwest Medical University (03212018xjd-XD1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}